PlumX Metrics
Embed PlumX Metrics

Use of a prenylation inhibitor as a novel antiviral agent

Journal of Virology, ISSN: 0022-538X, Vol: 72, Issue: 11, Page: 9303-9306
1998
  • 57
    Citations
  • 0
    Usage
  • 19
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

No specific therapy exists for hepatitis delta virus (HDV), which can cause severe liver disease. Molecular genetic studies have implicated the prenylation site of large delta antigen as a critical determinant of HDV particle assembly. We have established a cell culture model which produces HDV-like particles, and we show that delta antigen prenylation can be pharmacologically inhibited by the prenylation inhibitor BZA-5B. Furthermore, BZA-5B specifically abolishes particle production in a dose-dependent manner. These results demonstrate that the use of such a prenylation inhibitor-based antiviral therapy may be feasible and identify a novel class of potential antiviral agents.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know